胆性疹的皮肤反应模式
Ilona Shurmelova1, Agata Baldyga2, Eva Grekowitz3
1Department of Dermatology and Venerology, Kepler University Hospital, Linz, Austria.
概括
在胆性尿疹 (CholU) 患者中发现了六种不同的皮肤反应模式,其患病率和与疾病严重程度和出汗障碍相关性各不相同. 需要进一步的研究来将这些模式与治疗反应联系起来.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 过敏 过敏是一种过敏.
背景情况:
- 胆性疹 (CholU) 呈现出各种不同的皮肤反应.
- 这些模式的定义,患病率和临床意义尚未得到充分理解.
研究的目的:
- 在CholU.U.中定义和描述不同的皮肤反应模式.
- 调查这些模式的流行率和临床相关性.
主要方法:
- 患有CholU的患者接受了人体工程学挑测试.
- 分析了皮肤反应模式,基于小麦的特征和周围皮肤的反应.
主要成果:
- 确定了六种不同的CholU皮肤反应类型,患病率从11%到83%不等.
- 大多数患者 (94%) 呈现多种反应类型.
- 减少出汗是常见的,在VI型反应 (四肢) 中最明显.
- 类型V反应与严重的临床表现和生活质量差相关.
结论:
- 皮肤反应是多样化的,经常同时发生.
- 特定的皮肤症状与明显的临床特征和疾病严重程度有关.
- 未来的研究应该探索治疗反应与已识别的皮肤模式的相关性.
相关概念视频
Allergic Reactions
27.3K
Overview
27.3K
Allergic Drug Reactions
821
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
821
Hypersensitivities
559
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
559
Cholinergic Antagonists: Pharmacokinetics
423
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
423
Cholinergic Receptors: Muscarinic
2.0K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
2.0K
Cholinergic Antagonists: Pharmacological Actions
1.0K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.0K


